Andrea Corcoran

All filings by Andrea Corcoran on record concern Atea Pharmaceuticals, Inc. Over a trading history stretching from 31 January 2024 to 11 March 2026, the count stands at 4 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 13 March 2026 came the latest disclosure, an option exercise for €64k in Atea Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.